Ventricular tachycardia in acute fulminant myocarditis: Medical management and follow-up

Pediatric Cardiology

Volumn 29, Issue 2, 2008, Pages 416-419

  Sharma, J R ^a   Sathanandam, S ^a   Rao, S P ^a   Acharya, S ^b   Flood, V ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b University Hospital of Cornell ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Amiodarone; Fulminant myocarditis; Intravenous immunoglobulins; Ventricular ectopy

Indexed keywords

AMIODARONE; DIGOXIN; DOPAMINE; ENALAPRIL; ENOXAPARIN; FUROSEMIDE; IMMUNOGLOBULIN; SPIRONOLACTONE;

ANAMNESIS; ARTICLE; ASSISTED VENTILATION; CASE REPORT; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSFIBRINOGENEMIA; FEMALE; FOLLOW UP; HEART FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LABORATORY TEST; LIVER FUNCTION; LIVER TOXICITY; LOW DRUG DOSE; MYOCARDITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; THORAX RADIOGRAPHY;

ACUTE DISEASE; AMIODARONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MYOCARDITIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FUNCTION, LEFT;

EID: 40949145746     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9044-8     Document Type: Article

References (20)

1. Amabile N, Fraisse A, Chetaille P, et al. (2006) Outcome of acute fulminant myocarditis in children. Heart Online Jan 2006
2. Acker MA (2001) Mechanical circulatory support for patients with acute fulminant myocarditis. Ann Thorac Surg 71(Suppl 3):s73-s76
3. Balaji S, Wiles HB, Sens MA, Gillette PC (1994) Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 72(4):354-359
4. Cunnigham MT, Brandt JT, Laposata M, Olson JD (2002) Laboratory diagnosis of dysfibrogenemia. Arch Pathol Lab Med 126:499-505
5. Davis AM, Gow RM, McCrindle BW, Hamilton RM (1996) Clinical spectrum, therapeutic management and follow up of ventricular tachycardia in infants and children. Am Heart J 131(1):186-191
6. Drucker NA, Colan SD, Lewis AB, Wessel D, et al. (1994) Gamma globulin treatment of acute myocarditis in pediatric population. Circulation 89(1):252-257
7. Duncan BW, Bohn DJ, Atz AM, et al. (2001) Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 122(3):440-448
8. Del Nido PJ, Armitage JM, Fricker FJ, et al. (1994) Extracorporeal membrane oxygenation support as a bridge to pediatric heart transplantation. Circulation 90(5):1166-1169
9. Friedman RA, Kearney DL, Moak JP, Fenrich AL, Perry JC (1994) Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults. J Am Coll Cardiol 24(3):780-783
10. Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343(19):1388-1398
11. Grinda JM, Chevalier P, D'Attellis N, et al. (2005) Fulminant myocarditis in adults and children: biventricular assist device for recovery. Eur J Cardiothorac Surg 27(5):931-932
12. Klein RM, Vester EG, Brehm MU, et al. (2000) Inflammation of myocardium as an arrhythmia trigger. Z Kardiol 89(Suppl 3):24-35
13. Kim HS, Sohn S, Park JY, Seo JW (2004) Fulminant myocarditis successfully treated with high dose immunoglobulin. Letter to editor. Int J of Cardiol 96:485-486
14. Lee KJ, McCrindle BW, Bohn DJ, et al. (1999) Clinical outcomes of acute myocarditis in childhood. Heart 82(2):226-233
15. Lieberman EB, Hutchins GM, Herskowitz A, et al. (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18(7):1617-1626
16. Lewis JH, Ranard RC, Caruso A, et al. (1989) Amiodarone hepatotoxicity: prevalence and clnicopathologic correlation among 104 patients. Hepatology 9(5):679-685
17. McCarthy RE, Boehmer JP, Hruban RH, et al. (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690-695
18. Mecham N (2004) Acute viral myocarditis in the ED pediatric patients: three case presentations. J Emerg Nurs 30(2):179-182
19. Weller AH; Hall M; Huber SA (1992) Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis. Eur Heart J 13(1):115-119
20. Wiles HB, Gillette PC, Harley RA, Upshur JK (1992) Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J Am Coll Cardiol 20(2):359-362